JP2005529077A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005529077A5 JP2005529077A5 JP2003570846A JP2003570846A JP2005529077A5 JP 2005529077 A5 JP2005529077 A5 JP 2005529077A5 JP 2003570846 A JP2003570846 A JP 2003570846A JP 2003570846 A JP2003570846 A JP 2003570846A JP 2005529077 A5 JP2005529077 A5 JP 2005529077A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- methyl
- trifluoromethyl
- alkyl
- ethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 36
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 27
- 125000000217 alkyl group Chemical group 0.000 claims 23
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 22
- 125000004199 4-trifluoromethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C(F)(F)F 0.000 claims 13
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 11
- 235000019260 propionic acid Nutrition 0.000 claims 11
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 claims 11
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- 125000004496 thiazol-5-yl group Chemical group S1C=NC=C1* 0.000 claims 10
- 125000004104 aryloxy group Chemical group 0.000 claims 9
- -1 tetrahydropyranyloxy, morpholinyl Chemical group 0.000 claims 9
- 125000003118 aryl group Chemical group 0.000 claims 8
- 125000005110 aryl thio group Chemical group 0.000 claims 8
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims 8
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 7
- 125000004705 ethylthio group Chemical group C(C)S* 0.000 claims 7
- 125000001475 halogen functional group Chemical group 0.000 claims 6
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 claims 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 229910052799 carbon Inorganic materials 0.000 claims 4
- 125000004470 heterocyclooxy group Chemical group 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 125000003373 pyrazinyl group Chemical group 0.000 claims 3
- 125000004076 pyridyl group Chemical group 0.000 claims 3
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 3
- 125000001424 substituent group Chemical group 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- 125000006726 (C1-C5) alkenyl group Chemical group 0.000 claims 2
- 125000006727 (C1-C6) alkenyl group Chemical group 0.000 claims 2
- RIELTTJFAIMMOJ-UHFFFAOYSA-N 3-[2-methyl-4-[2-methyl-2-[5-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]propoxy]phenyl]propanoic acid Chemical compound CC=1SC(C=2C=CC(=CC=2)C(F)(F)F)=NC=1C(C)(C)COC1=CC=C(CCC(O)=O)C(C)=C1 RIELTTJFAIMMOJ-UHFFFAOYSA-N 0.000 claims 2
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 claims 2
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 claims 2
- 229910005965 SO 2 Inorganic materials 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 150000003857 carboxamides Chemical class 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 2
- 125000000524 functional group Chemical group 0.000 claims 2
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 125000004951 trihalomethoxy group Chemical group 0.000 claims 2
- 125000004953 trihalomethyl group Chemical group 0.000 claims 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- 125000006569 (C5-C6) heterocyclic group Chemical group 0.000 claims 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 claims 1
- FQDZPJAAONFQSD-LJQANCHMSA-N 2-[2-methyl-4-[(1r)-1-[4-(2-phenylethyl)-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenoxy]acetic acid Chemical compound O([C@H](C)C1=C(N=C(S1)C=1C=CC(=CC=1)C(F)(F)F)CCC=1C=CC=CC=1)C1=CC=C(OCC(O)=O)C(C)=C1 FQDZPJAAONFQSD-LJQANCHMSA-N 0.000 claims 1
- XIDQRQSMCPWFBE-LJQANCHMSA-N 2-[2-methyl-4-[(1r)-1-[4-(2-phenylethyl)-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethyl]sulfanylphenoxy]acetic acid Chemical compound S([C@H](C)C1=C(N=C(S1)C=1C=CC(=CC=1)C(F)(F)F)CCC=1C=CC=CC=1)C1=CC=C(OCC(O)=O)C(C)=C1 XIDQRQSMCPWFBE-LJQANCHMSA-N 0.000 claims 1
- XWQCYQDOPREOJB-OAHLLOKOSA-N 2-[2-methyl-4-[(1r)-1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenoxy]acetic acid Chemical compound O([C@H](C)C=1SC(=NC=1C(C)C)C=1C=CC(=CC=1)C(F)(F)F)C1=CC=C(OCC(O)=O)C(C)=C1 XWQCYQDOPREOJB-OAHLLOKOSA-N 0.000 claims 1
- OWDQZVUICOQNRV-OAHLLOKOSA-N 2-[2-methyl-4-[(1r)-1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethyl]sulfanylphenoxy]acetic acid Chemical compound S([C@H](C)C=1SC(=NC=1C(C)C)C=1C=CC(=CC=1)C(F)(F)F)C1=CC=C(OCC(O)=O)C(C)=C1 OWDQZVUICOQNRV-OAHLLOKOSA-N 0.000 claims 1
- XWQCYQDOPREOJB-HNNXBMFYSA-N 2-[2-methyl-4-[(1s)-1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenoxy]acetic acid Chemical compound O([C@@H](C)C=1SC(=NC=1C(C)C)C=1C=CC(=CC=1)C(F)(F)F)C1=CC=C(OCC(O)=O)C(C)=C1 XWQCYQDOPREOJB-HNNXBMFYSA-N 0.000 claims 1
- OWDQZVUICOQNRV-HNNXBMFYSA-N 2-[2-methyl-4-[(1s)-1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethyl]sulfanylphenoxy]acetic acid Chemical compound S([C@@H](C)C=1SC(=NC=1C(C)C)C=1C=CC(=CC=1)C(F)(F)F)C1=CC=C(OCC(O)=O)C(C)=C1 OWDQZVUICOQNRV-HNNXBMFYSA-N 0.000 claims 1
- FQDZPJAAONFQSD-UHFFFAOYSA-N 2-[2-methyl-4-[1-[4-(2-phenylethyl)-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenoxy]acetic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(CCC=2C=CC=CC=2)=C1C(C)OC1=CC=C(OCC(O)=O)C(C)=C1 FQDZPJAAONFQSD-UHFFFAOYSA-N 0.000 claims 1
- XIDQRQSMCPWFBE-UHFFFAOYSA-N 2-[2-methyl-4-[1-[4-(2-phenylethyl)-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethylsulfanyl]phenoxy]acetic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(CCC=2C=CC=CC=2)=C1C(C)SC1=CC=C(OCC(O)=O)C(C)=C1 XIDQRQSMCPWFBE-UHFFFAOYSA-N 0.000 claims 1
- UHZSDVNOWGZQIJ-UHFFFAOYSA-N 2-[2-methyl-4-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]-2-phenylethyl]sulfanylphenoxy]acetic acid Chemical compound CC=1N=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1C(SC=1C=C(C)C(OCC(O)=O)=CC=1)CC1=CC=CC=C1 UHZSDVNOWGZQIJ-UHFFFAOYSA-N 0.000 claims 1
- CJEZMYDRYWKBOK-UHFFFAOYSA-N 2-[2-methyl-4-[1-[4-phenyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethylsulfanyl]phenoxy]acetic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(C=2C=CC=CC=2)=C1C(C)SC1=CC=C(OCC(O)=O)C(C)=C1 CJEZMYDRYWKBOK-UHFFFAOYSA-N 0.000 claims 1
- XWQCYQDOPREOJB-UHFFFAOYSA-N 2-[2-methyl-4-[1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenoxy]acetic acid Chemical compound CC(C)C=1N=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1C(C)OC1=CC=C(OCC(O)=O)C(C)=C1 XWQCYQDOPREOJB-UHFFFAOYSA-N 0.000 claims 1
- OWDQZVUICOQNRV-UHFFFAOYSA-N 2-[2-methyl-4-[1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethylsulfanyl]phenoxy]acetic acid Chemical compound CC(C)C=1N=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1C(C)SC1=CC=C(OCC(O)=O)C(C)=C1 OWDQZVUICOQNRV-UHFFFAOYSA-N 0.000 claims 1
- WYWYSSDSZATLTG-MRXNPFEDSA-N 2-[4-[(1r)-1-[4-[(2-chloro-6-fluorophenoxy)methyl]-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethyl]sulfanyl-2-methylphenoxy]acetic acid Chemical compound S([C@H](C)C1=C(N=C(S1)C=1C=CC(=CC=1)C(F)(F)F)COC=1C(=CC=CC=1F)Cl)C1=CC=C(OCC(O)=O)C(C)=C1 WYWYSSDSZATLTG-MRXNPFEDSA-N 0.000 claims 1
- RMDYKBXFBHFGJV-QGZVFWFLSA-N 2-[4-[(1r)-1-[4-[2-(2-chloro-6-fluorophenyl)ethyl]-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethyl]sulfanyl-2-methylphenoxy]acetic acid Chemical compound S([C@H](C)C1=C(N=C(S1)C=1C=CC(=CC=1)C(F)(F)F)CCC=1C(=CC=CC=1F)Cl)C1=CC=C(OCC(O)=O)C(C)=C1 RMDYKBXFBHFGJV-QGZVFWFLSA-N 0.000 claims 1
- WYWYSSDSZATLTG-UHFFFAOYSA-N 2-[4-[1-[4-[(2-chloro-6-fluorophenoxy)methyl]-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(COC=2C(=CC=CC=2F)Cl)=C1C(C)SC1=CC=C(OCC(O)=O)C(C)=C1 WYWYSSDSZATLTG-UHFFFAOYSA-N 0.000 claims 1
- ZZYLGJYIVHRQFK-UHFFFAOYSA-N 2-[4-[1-[4-[2-(2-chloro-6-fluorophenyl)ethyl]-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]-2-methylphenoxy]acetic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(CCC=2C(=CC=CC=2F)Cl)=C1C(C)OC1=CC=C(OCC(O)=O)C(C)=C1 ZZYLGJYIVHRQFK-UHFFFAOYSA-N 0.000 claims 1
- RMDYKBXFBHFGJV-UHFFFAOYSA-N 2-[4-[1-[4-[2-(2-chloro-6-fluorophenyl)ethyl]-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(CCC=2C(=CC=CC=2F)Cl)=C1C(C)SC1=CC=C(OCC(O)=O)C(C)=C1 RMDYKBXFBHFGJV-UHFFFAOYSA-N 0.000 claims 1
- FCLKUFWAJLXFFO-UHFFFAOYSA-N 2-[4-[1-[4-ethyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]ethoxy]-2-methylphenoxy]acetic acid Chemical compound CCC=1N=C(C=2C=CC(=CC=2)C(F)(F)F)OC=1C(C)OC1=CC=C(OCC(O)=O)C(C)=C1 FCLKUFWAJLXFFO-UHFFFAOYSA-N 0.000 claims 1
- XGYOUMVNQVZLBY-UHFFFAOYSA-N 2-[4-[1-[4-ethyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]ethylsulfanyl]-2-methylphenoxy]acetic acid Chemical compound CCC=1N=C(C=2C=CC(=CC=2)C(F)(F)F)OC=1C(C)SC1=CC=C(OCC(O)=O)C(C)=C1 XGYOUMVNQVZLBY-UHFFFAOYSA-N 0.000 claims 1
- AWPKQIVBUIVRCN-MRXNPFEDSA-N 3-[2-methyl-4-[(1r)-1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound O([C@H](C)C=1SC(=NC=1C(C)C)C=1C=CC(=CC=1)C(F)(F)F)C1=CC=C(CCC(O)=O)C(C)=C1 AWPKQIVBUIVRCN-MRXNPFEDSA-N 0.000 claims 1
- MYPWXSGXJQAYEH-HNNXBMFYSA-N 3-[2-methyl-4-[(1s)-1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound O([C@@H](C)C1=C(N=C(S1)C=1C=CC(=CC=1)C(F)(F)F)C)C1=CC=C(CCC(O)=O)C(C)=C1 MYPWXSGXJQAYEH-HNNXBMFYSA-N 0.000 claims 1
- AWPKQIVBUIVRCN-INIZCTEOSA-N 3-[2-methyl-4-[(1s)-1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound O([C@@H](C)C=1SC(=NC=1C(C)C)C=1C=CC(=CC=1)C(F)(F)F)C1=CC=C(CCC(O)=O)C(C)=C1 AWPKQIVBUIVRCN-INIZCTEOSA-N 0.000 claims 1
- BVFSSXGJVXHYQD-HNNXBMFYSA-N 3-[2-methyl-4-[(2r)-2-[5-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-4-yl]propyl]sulfanylphenyl]propanoic acid Chemical compound C([C@H](C)C1=C(SC(=N1)C=1C=CC(=CC=1)C(F)(F)F)C)SC1=CC=C(CCC(O)=O)C(C)=C1 BVFSSXGJVXHYQD-HNNXBMFYSA-N 0.000 claims 1
- HRTBEAMEOCUEHU-UHFFFAOYSA-N 3-[2-methyl-4-[1-[2-(3-morpholin-4-ylphenyl)-4-propan-2-yl-1,3-oxazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound CC(C)C=1N=C(C=2C=C(C=CC=2)N2CCOCC2)OC=1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 HRTBEAMEOCUEHU-UHFFFAOYSA-N 0.000 claims 1
- KTZLIPGEIYQWJU-UHFFFAOYSA-N 3-[2-methyl-4-[1-[2-(3-piperidin-1-ylphenyl)-4-propan-2-yl-1,3-oxazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound CC(C)C=1N=C(C=2C=C(C=CC=2)N2CCCCC2)OC=1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 KTZLIPGEIYQWJU-UHFFFAOYSA-N 0.000 claims 1
- KBKAQXZPPGPXAD-UHFFFAOYSA-N 3-[2-methyl-4-[1-[2-(4-morpholin-4-ylphenyl)-4-propan-2-yl-1,3-oxazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound CC(C)C=1N=C(C=2C=CC(=CC=2)N2CCOCC2)OC=1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 KBKAQXZPPGPXAD-UHFFFAOYSA-N 0.000 claims 1
- ZEFPIRIYJAPQPG-UHFFFAOYSA-N 3-[2-methyl-4-[1-[2-(4-piperidin-1-ylphenyl)-4-propan-2-yl-1,3-oxazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound CC(C)C=1N=C(C=2C=CC(=CC=2)N2CCCCC2)OC=1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 ZEFPIRIYJAPQPG-UHFFFAOYSA-N 0.000 claims 1
- JPWCJWUUJLVSDX-UHFFFAOYSA-N 3-[2-methyl-4-[1-[2-[3-(oxan-4-yloxy)phenyl]-4-propan-2-yl-1,3-oxazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound CC(C)C=1N=C(C=2C=C(OC3CCOCC3)C=CC=2)OC=1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 JPWCJWUUJLVSDX-UHFFFAOYSA-N 0.000 claims 1
- JEUYRMGHAGJHBW-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]but-3-enoxy]phenyl]propanoic acid Chemical compound CC=1N=C(C=2C=CC(=CC=2)C(F)(F)F)OC=1C(CC=C)OC1=CC=C(CCC(O)=O)C(C)=C1 JEUYRMGHAGJHBW-UHFFFAOYSA-N 0.000 claims 1
- MWRUOVTUHNCAPT-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]butoxy]phenyl]propanoic acid Chemical compound O1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(C)=C1C(CCC)OC1=CC=C(CCC(O)=O)C(C)=C1 MWRUOVTUHNCAPT-UHFFFAOYSA-N 0.000 claims 1
- BRTFMXXYTUZGKY-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound O1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(C)=C1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 BRTFMXXYTUZGKY-UHFFFAOYSA-N 0.000 claims 1
- KZCSYBFKHPXVLC-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]pentoxy]phenyl]propanoic acid Chemical compound O1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(C)=C1C(CCCC)OC1=CC=C(CCC(O)=O)C(C)=C1 KZCSYBFKHPXVLC-UHFFFAOYSA-N 0.000 claims 1
- ULVMSXUCWAUANG-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]propoxy]phenyl]propanoic acid Chemical compound O1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(C)=C1C(CC)OC1=CC=C(CCC(O)=O)C(C)=C1 ULVMSXUCWAUANG-UHFFFAOYSA-N 0.000 claims 1
- GYFJTUCUQQROME-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]-2-phenylethoxy]phenyl]propanoic acid Chemical compound CC=1N=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1C(OC=1C=C(C)C(CCC(O)=O)=CC=1)CC1=CC=CC=C1 GYFJTUCUQQROME-UHFFFAOYSA-N 0.000 claims 1
- MYPWXSGXJQAYEH-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(C)=C1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 MYPWXSGXJQAYEH-UHFFFAOYSA-N 0.000 claims 1
- XFNTVTMUDBEFQP-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-phenyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(C=2C=CC=CC=2)=C1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 XFNTVTMUDBEFQP-UHFFFAOYSA-N 0.000 claims 1
- LRSKXLDJOWWFSP-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound CC(C)C=1N=C(C=2C=CC(=CC=2)C(F)(F)F)OC=1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 LRSKXLDJOWWFSP-UHFFFAOYSA-N 0.000 claims 1
- AWPKQIVBUIVRCN-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]phenyl]propanoic acid Chemical compound CC(C)C=1N=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 AWPKQIVBUIVRCN-UHFFFAOYSA-N 0.000 claims 1
- BSUCVBVDGVTBFJ-UHFFFAOYSA-N 3-[2-methyl-4-[1-[4-propan-2-yl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethylsulfanyl]phenyl]propanoic acid Chemical compound CC(C)C=1N=C(C=2C=CC(=CC=2)C(F)(F)F)SC=1C(C)SC1=CC=C(CCC(O)=O)C(C)=C1 BSUCVBVDGVTBFJ-UHFFFAOYSA-N 0.000 claims 1
- YNHDIWFFCZAIOJ-UHFFFAOYSA-N 3-[2-methyl-4-[2-[5-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-4-yl]propoxy]phenyl]propanoic acid Chemical compound N1=C(C=2C=CC(=CC=2)C(F)(F)F)OC(C)=C1C(C)COC1=CC=C(CCC(O)=O)C(C)=C1 YNHDIWFFCZAIOJ-UHFFFAOYSA-N 0.000 claims 1
- QAGVLZPIONQLNN-KRWDZBQOSA-N 3-[4-[(1s)-1-[4-[(2-chloro-6-fluorophenoxy)methyl]-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]-2-methylphenyl]propanoic acid Chemical compound O([C@@H](C)C1=C(N=C(S1)C=1C=CC(=CC=1)C(F)(F)F)COC=1C(=CC=CC=1F)Cl)C1=CC=C(CCC(O)=O)C(C)=C1 QAGVLZPIONQLNN-KRWDZBQOSA-N 0.000 claims 1
- JURDPNPQVAXTQS-UHFFFAOYSA-N 3-[4-[1-[2-(3-cyclopentyloxyphenyl)-4-propan-2-yl-1,3-oxazol-5-yl]ethoxy]-2-methylphenyl]propanoic acid Chemical compound CC(C)C=1N=C(C=2C=C(OC3CCCC3)C=CC=2)OC=1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 JURDPNPQVAXTQS-UHFFFAOYSA-N 0.000 claims 1
- NBFXUWCHZDMOGI-UHFFFAOYSA-N 3-[4-[1-[2-(4-cyclopentyloxyphenyl)-4-propan-2-yl-1,3-oxazol-5-yl]ethoxy]-2-methylphenyl]propanoic acid Chemical compound CC(C)C=1N=C(C=2C=CC(OC3CCCC3)=CC=2)OC=1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 NBFXUWCHZDMOGI-UHFFFAOYSA-N 0.000 claims 1
- KGJDJLZRBHDPQP-UHFFFAOYSA-N 3-[4-[1-[4-[[3,5-bis(trifluoromethyl)phenoxy]methyl]-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]ethoxy]-2-methylphenyl]propanoic acid Chemical compound S1C(C=2C=CC(=CC=2)C(F)(F)F)=NC(COC=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 KGJDJLZRBHDPQP-UHFFFAOYSA-N 0.000 claims 1
- WNPISDSTXJLULM-UHFFFAOYSA-N 3-[4-[1-[4-ethyl-2-[4-(trifluoromethyl)phenyl]-1,3-oxazol-5-yl]ethoxy]-2-methylphenyl]propanoic acid Chemical compound CCC=1N=C(C=2C=CC(=CC=2)C(F)(F)F)OC=1C(C)OC1=CC=C(CCC(O)=O)C(C)=C1 WNPISDSTXJLULM-UHFFFAOYSA-N 0.000 claims 1
- BAYGVMXZJBFEMB-UHFFFAOYSA-N 4-(trifluoromethyl)phenol Chemical compound OC1=CC=C(C(F)(F)F)C=C1 BAYGVMXZJBFEMB-UHFFFAOYSA-N 0.000 claims 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 1
- 101150065749 Churc1 gene Proteins 0.000 claims 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims 1
- 102100038239 Protein Churchill Human genes 0.000 claims 1
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical group C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000005002 aryl methyl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- CWGGRDNQUTYLKC-UHFFFAOYSA-N methyl 3-[2-methyl-4-[1-[4-propan-2-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1,3-oxazol-5-yl]ethoxy]phenyl]propanoate Chemical compound C1=C(C)C(CCC(=O)OC)=CC=C1OC(C)C1=C(C(C)C)N=C(C=2C=CC(=CC=2)B2OC(C)(C)C(C)(C)O2)O1 CWGGRDNQUTYLKC-UHFFFAOYSA-N 0.000 claims 1
- TYGBXZGEVNLUJJ-UHFFFAOYSA-N methyl 3-[4-[1-[2-(4-hydroxyphenyl)-4-propan-2-yl-1,3-oxazol-5-yl]ethoxy]-2-methylphenyl]propanoate Chemical compound C1=C(C)C(CCC(=O)OC)=CC=C1OC(C)C1=C(C(C)C)N=C(C=2C=CC(O)=CC=2)O1 TYGBXZGEVNLUJJ-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 102000005962 receptors Human genes 0.000 claims 1
- 108020003175 receptors Proteins 0.000 claims 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 claims 1
- 125000003944 tolyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35980802P | 2002-02-25 | 2002-02-25 | |
| PCT/US2003/002679 WO2003072100A1 (en) | 2002-02-25 | 2003-02-13 | Peroxisome proliferator activated receptor modulators |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005529077A JP2005529077A (ja) | 2005-09-29 |
| JP2005529077A5 true JP2005529077A5 (https=) | 2006-01-05 |
Family
ID=27766138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003570846A Pending JP2005529077A (ja) | 2002-02-25 | 2003-02-13 | ペルオキシソーム増殖因子活性化受容体調節物質 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7153878B2 (https=) |
| EP (1) | EP1480640B1 (https=) |
| JP (1) | JP2005529077A (https=) |
| AT (1) | ATE369855T1 (https=) |
| AU (1) | AU2003217274A1 (https=) |
| DE (1) | DE60315603T2 (https=) |
| ES (1) | ES2290439T3 (https=) |
| WO (1) | WO2003072100A1 (https=) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040072838A1 (en) * | 2000-12-20 | 2004-04-15 | Pierette Banker | Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors |
| US7105551B2 (en) * | 2000-12-20 | 2006-09-12 | Smithkline Beecham Corporation | Thiazole derivatives for treating PPAR related disorders |
| ES2290439T3 (es) | 2002-02-25 | 2008-02-16 | Eli Lilly And Company | Moduladores del receptor activado del proliferador de peroxisomas. |
| AU2004247355A1 (en) | 2003-06-06 | 2004-12-23 | F. Hoffmann-La Roche Ag | Aniline derivatives |
| ES2390053T3 (es) * | 2003-09-22 | 2012-11-06 | Ono Pharmaceutical Co., Ltd. | Derivado de ácido fenilacético, procedimiento para producir el mismo y uso |
| CN1875002B (zh) * | 2003-11-05 | 2011-08-03 | 霍夫曼-拉罗奇有限公司 | 作为ppar激动剂的苯基衍生物 |
| EP1682507A1 (en) * | 2003-11-05 | 2006-07-26 | F. Hoffmann-La Roche Ag | Benzannelated compounds as ppar activators |
| WO2005060958A1 (en) * | 2003-12-19 | 2005-07-07 | Kalypsys, Inc. | (5- (2-phenyl)-thiazol-5-ylmethoxy)-indol-1-yl) -acetic acid derivatives and related compounds as modulators of the human ppar-delta receptor for the treatment of metabolic disorders such as type 2 diabetes |
| US7786165B2 (en) | 2004-03-15 | 2010-08-31 | Takeda Pharmaceutical Company Limited | Aminophenylpropanoic acid derivative |
| DE602005024384D1 (de) | 2004-05-05 | 2010-12-09 | High Point Pharmaceuticals Llc | Neue verbindungen, ihre herstellung und verwendung |
| US8053598B2 (en) | 2004-05-05 | 2011-11-08 | High Point Pharmaceuticals, Llc | Compounds, their preparation and use |
| DE102004040736B4 (de) * | 2004-08-23 | 2007-01-11 | Sanofi-Aventis Deutschland Gmbh | Verfahren zur Herstellung von Diarylcycloalkylderivaten |
| CN101146784B (zh) * | 2005-02-25 | 2012-09-05 | 财团法人首尔大学校产学协力财团 | 作为PPARδ配体的噻唑衍生物及其制造方法 |
| EP1856072A4 (en) * | 2005-02-25 | 2009-10-21 | Seoul Nat Univ Ind Foundation | THIAZOLE DERIVATIVES AS PPAR DELTA LIGANDS AND PROCESSES FOR THE PRODUCTION THEREOF |
| ES2372617T3 (es) | 2005-06-30 | 2012-01-24 | High Point Pharmaceuticals, Llc | Ácidos fenoxiacéticos como activadores de ppar-delta. |
| AU2006299092A1 (en) * | 2005-09-29 | 2007-04-12 | Sanofi-Aventis | Phenyl-(1,2,4)-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals |
| CN103224477A (zh) | 2005-12-22 | 2013-07-31 | 高点制药有限责任公司 | 作为PPAR-δ活化剂的苯氧基乙酸 |
| US8748627B2 (en) | 2006-02-15 | 2014-06-10 | Abbvie Inc. | Acetyl-CoA carboxylase (ACC) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| CN101384568B (zh) | 2006-02-15 | 2012-12-12 | 雅培制药有限公司 | 乙酰辅酶a羧化酶(acc)抑制剂及其在糖尿病、肥胖症和代谢综合征中的应用 |
| US7943612B2 (en) | 2006-03-09 | 2011-05-17 | High Point Pharmaceuticals, Llc | Compounds that modulate PPAR activity, their preparation and use |
| CN101466687B (zh) * | 2006-04-18 | 2012-04-11 | 日本化学医药株式会社 | 过氧化物酶体增殖剂激活受体δ的激活剂 |
| US8519145B2 (en) | 2006-12-02 | 2013-08-27 | Seoul National University Industry Foundation | Aryl compounds as PPAR ligands and their use |
| RU2444518C2 (ru) * | 2007-01-08 | 2012-03-10 | Сеул Нэшнл Юниверсити Индастри Фаундейшн | ПРОИЗВОДНОЕ ТИАЗОЛА КАК PPARδ ЛИГАНД И ФАРМАЦЕВТИЧЕСКИЙ, КОСМЕТИЧЕСКИЙ И ДИЕТИЧЕСКИЙ ПИЩЕВОЙ ПРОДУКТ, СОДЕРЖАЩИЙ ЕГО |
| WO2008154023A1 (en) * | 2007-06-11 | 2008-12-18 | Cerenis Therapeutics S.A. | Novel uses of ppar delta agonists |
| WO2010047982A1 (en) | 2008-10-22 | 2010-04-29 | Merck Sharp & Dohme Corp. | Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| JP5557845B2 (ja) | 2008-10-31 | 2014-07-23 | メルク・シャープ・アンド・ドーム・コーポレーション | 糖尿病用剤として有用な新規環状ベンゾイミダゾール誘導体 |
| US8895596B2 (en) | 2010-02-25 | 2014-11-25 | Merck Sharp & Dohme Corp | Cyclic benzimidazole derivatives useful as anti-diabetic agents |
| EP2540711A4 (en) * | 2010-02-25 | 2014-01-22 | Snu R&Db Foundation | Selenium-Zolderivate with ligand for the activation of the peroxisome-proliferator-activated receptor (PPAR), preparation method therefor and use of the chemical compounds |
| RU2013114390A (ru) | 2010-08-31 | 2014-10-10 | СНУ Ар энд ДиБи ФАУНДЕЙШН | Применение фетального репрограммирования посредством ppar-дельта-агониста |
| BR112013021236B1 (pt) | 2011-02-25 | 2021-05-25 | Merck Sharp & Dohme Corp | composto derivado de benzimidazol, e, composição |
| US9688673B2 (en) | 2011-03-08 | 2017-06-27 | The Regents Of The University Of California | Deoxycytidine kinase binding compounds |
| US9527875B2 (en) | 2012-08-02 | 2016-12-27 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| US20160029630A1 (en) | 2012-11-27 | 2016-02-04 | Basf Se | Substituted 2-[phenoxy-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds and their use as fungicides |
| WO2014082871A1 (en) | 2012-11-27 | 2014-06-05 | Basf Se | Substituted 2-[phenoxy-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds and their use as fungicides |
| US20150313229A1 (en) | 2012-11-27 | 2015-11-05 | Basf Se | Substituted [1,2,4] Triazole Compounds |
| RU2015140066A (ru) | 2013-02-22 | 2017-03-30 | Мерк Шарп И Доум Корп. | Противодиабетические бициклические соединения |
| WO2014139388A1 (en) | 2013-03-14 | 2014-09-18 | Merck Sharp & Dohme Corp. | Novel indole derivatives useful as anti-diabetic agents |
| EP3756661A1 (en) | 2013-09-09 | 2020-12-30 | vTv Therapeutics LLC | Use of a ppar-delta agonist for treating muscle atrophy |
| WO2015051496A1 (en) | 2013-10-08 | 2015-04-16 | Merck Sharp & Dohme Corp. | Antidiabetic tricyclic compounds |
| EP3116503A4 (en) * | 2014-03-14 | 2017-08-23 | Aerpio Therapeutics, Inc. | Hptp-beta inhibitors |
| AR100743A1 (es) | 2014-06-06 | 2016-10-26 | Basf Se | Compuestos de [1,2,4]triazol sustituido |
| US11072602B2 (en) | 2016-12-06 | 2021-07-27 | Merck Sharp & Dohme Corp. | Antidiabetic heterocyclic compounds |
| WO2018118670A1 (en) | 2016-12-20 | 2018-06-28 | Merck Sharp & Dohme Corp. | Antidiabetic spirochroman compounds |
| CN109897013B (zh) * | 2019-03-31 | 2023-04-07 | 无锡科华生物科技有限公司 | 一种选择性PPARδ激动剂GW501516的制备方法 |
| US11634387B2 (en) | 2019-09-26 | 2023-04-25 | Abionyx Pharma Sa | Compounds useful for treating liver diseases |
| CN113912547B (zh) | 2020-07-10 | 2024-04-30 | 成都凡诺西生物医药科技有限公司 | 取代苯丙咪唑类衍生物及其应用 |
| MX2023005056A (es) | 2020-11-02 | 2023-07-24 | Trethera Corp | Formas cristalinas de un inhibidor de cinasa de desoxicitidina y sus usos. |
| WO2022189856A1 (en) * | 2021-03-08 | 2022-09-15 | Abionyx Pharma Sa | Compounds useful for treating liver diseases |
| WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204277B1 (en) * | 1996-08-19 | 2001-03-20 | Japan Tobacco Inc. | Propionic acid derivatives and applications thereof |
| GB9914977D0 (en) * | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
| US6787552B2 (en) * | 2000-08-11 | 2004-09-07 | Nippon Chemiphar Co., Ltd. | PPAR delta activators |
| DE60129712T2 (de) * | 2000-08-23 | 2008-07-03 | Eli Lilly And Co., Indianapolis | Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten |
| GB0031107D0 (en) | 2000-12-20 | 2001-01-31 | Glaxo Group Ltd | Chemical compounds |
| ES2290439T3 (es) | 2002-02-25 | 2008-02-16 | Eli Lilly And Company | Moduladores del receptor activado del proliferador de peroxisomas. |
-
2003
- 2003-02-13 ES ES03713316T patent/ES2290439T3/es not_active Expired - Lifetime
- 2003-02-13 AT AT03713316T patent/ATE369855T1/de not_active IP Right Cessation
- 2003-02-13 US US10/505,089 patent/US7153878B2/en not_active Expired - Fee Related
- 2003-02-13 DE DE60315603T patent/DE60315603T2/de not_active Expired - Fee Related
- 2003-02-13 EP EP03713316A patent/EP1480640B1/en not_active Expired - Lifetime
- 2003-02-13 AU AU2003217274A patent/AU2003217274A1/en not_active Abandoned
- 2003-02-13 WO PCT/US2003/002679 patent/WO2003072100A1/en not_active Ceased
- 2003-02-13 JP JP2003570846A patent/JP2005529077A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005529077A5 (https=) | ||
| KR101179087B1 (ko) | 인간 단백질 티로신 포스파타아제 억제제 및 이용 방법 | |
| ES2522291T3 (es) | Agente activador para el receptor activado por el proliferador de peroxisomas | |
| RU2018138707A (ru) | Замещенные гетероарилом пиридины и способы применения | |
| JP2019517455A5 (https=) | ||
| JP2004534035A5 (https=) | ||
| RU2419624C2 (ru) | Сульфонамидные производные как активаторы гликокиназы, применимые для лечения диабета типа 2 | |
| ES2290439T3 (es) | Moduladores del receptor activado del proliferador de peroxisomas. | |
| RU2009102537A (ru) | Ингибиторы белок-тирозинфосфатазы человека и способы применения | |
| JP2007520471A5 (https=) | ||
| RU2009102516A (ru) | Ингибиторы протеинтирозинфосфатазы человека и способы их использования | |
| JP2002522426A (ja) | ｈＰＰＡＲγおよびｈＰＰＡＲαアクチベーターとしての置換オキサゾール類およびチアゾール類誘導体 | |
| JP2004529174A5 (https=) | ||
| JP2005502600A5 (https=) | ||
| RU2383524C2 (ru) | Гексафторизопропанол-замещенные производные простых эфиров | |
| JP2004518702A5 (https=) | ||
| JP2010506825A5 (https=) | ||
| JP2004509084A5 (https=) | ||
| KR970703340A (ko) | 과혈당 치료제로서의 신규한 아졸리딘디온(New azolidinediones as antihyperglycemic agents) | |
| JP2006516251A5 (https=) | ||
| RU2006123559A (ru) | Биарилсульфонамиды в качестве ммр-ингибиторов | |
| JP2014523400A5 (https=) | ||
| CA2575081A1 (en) | Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses | |
| JP2008507579A5 (https=) | ||
| RU2415846C2 (ru) | Производные, имеющие активность агонистов ppar-рецепторов |